Norman Sussman
Hepatology · Houston, TXNPI 1578643813
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Gilead at 31.8% of the total.
Across 80 payments — averaging $565.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$14K
- AbbVie$12K
- AstraZeneca$9K
- Intercept Pharmaceuticals, Inc.$7K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
- Eisai Inc.$180
- plus $196 from 2 others
Across 40 payments — averaging $6868.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$248K
- AbbVie$27K
What the payments were for
- Consulting fees$13,67030%
- Speaking & faculty fees$22,47650%
- Travel & lodging$6,95015%
- Food & beverage$2,1245%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 24 | $14,387 |
| AbbVie | 31 | $12,358 |
| AstraZeneca | 2 | $8,500 |
| Intercept Pharmaceuticals, Inc. | 16 | $7,087 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $2,512 |
| Eisai Inc. | 3 | $180 |
| Fujifilm Wako Diagnostics U.S.A. Corporation | 1 | $126 |
| Dova Pharmaceuticals | 1 | $71 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epclusa$13,289
- Mavyret$7,285
- XIFAXAN$2,500
- OCALIVA$500
- Wako HCC Biomarker(s) DCP and AFP-L3$126
How this compares
$45,220 in reported general payments places this provider in the 65th percentile of 22 hepatology providers in Texas.
Other hepatology in Houston
- Joseph GalatiHouston$211K
- Tuan PhamHouston$39K
- Maryam ZaferHouston$695
- Rise StriblingHouston$25
- Amit SingalDallas$534K
- Willis MaddreyDallas$289K
- Hesham ElgouhariDenison$147K
- Rashmee PatilMcAllen$146K
- William LeeDallas$101K
- Marlyn MayoDallas$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.